Click on headlines below to download research

Year-end update highlights transaction potential
ReNeuron Group | 20/05/2019

ReNeuron’s year-end update summarised its recent clinical progress in the human retinal progenitor cell (hRPC) programme in retinitis pigmentosa…

Early clinical data in RP continue to improve
ReNeuron Group | 26/04/2019

ReNeuron has released further data on the first three retinitis pigmentosa (RP) patients dosed with its human retinal progenitor cell (hRPC) product. Improvements…

Long-awaited partnering floodgates open
ReNeuron Group | 11/04/2019

Following-on from ReNeuron’s recent striking early-stage data release for its human retinal progenitor cell (hRPC) product in retinitis pigmentosa…